Form SC 13G - Statement of Beneficial Ownership by Certain Investors:
SEC Accession No. 0001193125-20-117194
Filing Date
2020-04-23
Accepted
2020-04-23 16:17:05
Documents
1
Group Members
WUXI HEALTHCARE MANAGEMENT, LLC

Document Format Files

Seq Description Document Type Size
1 SC 13G d884284dsc13g.htm SC 13G 54355
  Complete submission text file 0001193125-20-117194.txt   56111
Mailing Address C/O MAPLES CORPORATE SERVICES LIMITED P.O. BOX 309, UGLAND HOUSE GRAND CAYMAN E9 KY1-1104
Business Address C/O MAPLES CORPORATE SERVICES LIMITED P.O. BOX 309, UGLAND HOUSE GRAND CAYMAN E9 KY1-1104 345-949-8066
WuXi Healthcare Ventures II, L.P. (Filed by) CIK: 0001647651 (see all company filings)

EIN.: 000000000 | State of Incorp.: E9 | Fiscal Year End: 1231
Type: SC 13G

Mailing Address 7000 SHORELINE COURT, SUITE 350 SOUTH SAN FRANCISCO CA 94080
Business Address 7000 SHORELINE COURT, SUITE 350 SOUTH SAN FRANCISCO CA 94080 650-443-6209
IDEAYA Biosciences, Inc. (Subject) CIK: 0001676725 (see all company filings)

EIN.: 474268251 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G | Act: 34 | File No.: 005-91018 | Film No.: 20811217
SIC: 2834 Pharmaceutical Preparations